Battling against radiotherapy-induced immune tolerance in colorectal cancer: potential synergistic effects of VISTA and CD39 inhibitors-Reference-Cited by-同舟云学术

Battling against radiotherapy-induced immune tolerance in colorectal cancer: potential synergistic effects of VISTA and CD39 inhibitors

Published:2023-10-25 Issue:12 Volume:35 Page:1416-1416
ISSN:0954-691X
Container-title:European Journal of Gastroenterology & Hepatology
language:en
Short-container-title:

Author:

Li Tianhang¹²,Lin Yunzhen³,Li Xiangyang⁴

Affiliation:

1. Department of Urology, Zhongda Hospital, Southeast University

2. Surgical Research Center, Institute of Urology, Southeast University Medical School

3. Department of General Surgery, Nanjing BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University

4. Department of General Surgery, The Second Hospital of Chinese Medicine, The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference5 articles.

1. CD39 inhibition and VISTA blockade may overcome radiotherapy resistance by targeting exhausted CD8+ T cells and immunosuppressive myeloid cells.;Zhang;Cell Rep Med,2023

2. Treatment of metastatic colorectal cancer: ASCO guideline.;Morris;J Clin Oncol,2023

3. Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial.;Lancet Oncol,2012

4. First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials.;Wasan;Lancet Oncol,2017

5. Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates.;Simoni;Nature,2018